Literature DB >> 9268345

Initiation of osteoclast bone resorption by interstitial collagenase.

L S Holliday1, H G Welgus, C J Fliszar, G M Veith, J J Jeffrey, S L Gluck.   

Abstract

Osteoclasts form an acidic compartment at their attachment site in which bone demineralization and matrix degradation occur. Although both the cysteine proteinases and neutral collagenases participate in bone resorption, their roles have remained unclear. Here we show that interstitial collagenase has an essential role in initiating bone resorption, distinct from that of the cysteine proteinases. Treatment of osteoclasts with cysteine proteinase inhibitors did not affect the number of resorption lacunae ("pits") formed on the surface of dentine slices, but it generated abnormal pits that were demineralized but filled with undegraded matrix. Treatment with metalloproteinase inhibitors did not alter the qualitative features of lacunae, but it greatly reduced the number of pits and surface area resorbed. Treatment of bone cells with an inhibitory anti-rat interstitial collagenase antiserum reduced bone resorption markedly. In the presence of collagenase inhibitors, resorption was restored by pretreatment of dentine slices with rat interstitial collagenase or by precoating the dentine slices with collagenase-derived gelatin peptides or heat-gelatinized collagen. Immunostaining revealed that interstitial collagenase is produced at high levels by stromal cells and osteoblasts adjacent to osteoclasts. These results indicate that interstitial collagenase can function as a "coupling factor," allowing osteoblasts to initiate bone resorption by generating collagen fragments that activate osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9268345     DOI: 10.1074/jbc.272.35.22053

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Collagenase expression and activity in the stromal cells from giant cell tumour of bone.

Authors:  Robert W Cowan; Isabella W Y Mak; Nigel Colterjohn; Gurmit Singh; Michelle Ghert
Journal:  Bone       Date:  2009-02-12       Impact factor: 4.398

2.  Relationship of circulating MMP-2, MMP-1, and TIMP-1 levels with bone biochemical markers and bone mineral density in postmenopausal Chinese women.

Authors:  X-H Luo; L-J Guo; P-F Shan; H Xie; X-P Wu; H Zhang; X-Z Cao; L-Q Yuan; E-Y Liao
Journal:  Osteoporos Int       Date:  2005-12-20       Impact factor: 4.507

3.  Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model.

Authors:  S M Eck; P J Hoopes; B L Petrella; C I Coon; C E Brinckerhoff
Journal:  Breast Cancer Res Treat       Date:  2008-07-03       Impact factor: 4.872

Review 4.  Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later.

Authors:  George Hajishengallis; Jonathan M Korostoff
Journal:  Periodontol 2000       Date:  2017-10       Impact factor: 7.589

5.  TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.

Authors:  A R Pettit; H Ji; D von Stechow; R Müller; S R Goldring; Y Choi; C Benoist; E M Gravallese
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

6.  Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway.

Authors:  Melissa M Matzelle; Maxime A Gallant; Keith W Condon; Nicole C Walsh; Catherine A Manning; Gary S Stein; Jane B Lian; David B Burr; Ellen M Gravallese
Journal:  Arthritis Rheum       Date:  2012-05

7.  Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model.

Authors:  Els Van Valckenborgh; Peter I Croucher; Hendrik De Raeve; Chris Carron; Evy De Leenheer; Sylvia Blacher; Laetitia Devy; Agnès Noël; Elke De Bruyne; Kewal Asosingh; Ivan Van Riet; Ben Van Camp; Karin Vanderkerken
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Bone is not essential for osteoclast activation.

Authors:  Karen Fuller; Jade L Ross; Kinga A Szewczyk; Raymond Moss; Tim J Chambers
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

9.  MMP-13 is over-expressed in renal cell carcinoma bone metastasis and is induced by TGF-beta1.

Authors:  Scott L Kominsky; Michele Doucet; Margaret Thorpe; Kristy L Weber
Journal:  Clin Exp Metastasis       Date:  2008-08-16       Impact factor: 5.150

10.  Identification of enoxacin as an inhibitor of osteoclast formation and bone resorption by structure-based virtual screening.

Authors:  David A Ostrov; Andrew T Magis; Thomas J Wronski; Edward K L Chan; Edgardo J Toro; Richard E Donatelli; Kristen Sajek; Ireni N Haroun; Michael I Nagib; Ana Piedrahita; Ashley Harris; L Shannon Holliday
Journal:  J Med Chem       Date:  2009-08-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.